XML 41 R27.htm IDEA: XBRL DOCUMENT
v3.23.1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES | 12 Months Ended
--- | ---
Dec. 31, 2022
Payables and Accruals [Abstract] |
ACCOUNTS PAYABLE AND ACCRUED EXPENSES | 21. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Other current liabilities at December 31, 2022 and 2021 consisted of:
Schedule of other current liabilities |  |  |  |  |  |  |  |
|  | December 31, |
|  | 2022 |  |  | 2021 |
Accounts payable |  | $ | 21,347,000 |  |  | $ | 6,902,000 |
Accrued payroll and payroll taxes |  |  | 9,939,000 |  |  |  | 5,027,000 |
Accrued lender profit participation rights |  |  | 6,000,000 |  |  |  | - |
Interest payable |  |  | 3,207,000 |  |  |  | 187,000 |
Accrued legal |  |  | 3,168,000 |  |  |  | 2,637,000 |
Advances from related parties |  |  | 352,000 |  |  |  | - |
Financial instrument liabilities |  |  | 651,000 |  |  |  | 4,249,000 |
Other accrued expenses |  |  | 17,980,000 |  |  |  | 3,753,000 |
Total liabilities |  | $ | 62,644,000 |  |  | $ | 22,755,000 |
Accrued Lender Profit Participation Rights The accrued lender profit participation rights relate to the November 18, 2022 secured promissory notes. The secured promissory notes have a security interest in certain marketable securities to be acquired by BNI (the “Participation Collateral”). When the Company sells the Participation Collateral, the Company is required to give the investors a profits participation interest equal to 45% of the realized gains. The Company estimated the profit participation right resulting in a $6.0 million estimated liability based on 45% of the expected realized gain as of December 31, 2022. Financial Instruments Under authoritative guidance used by the FASB on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock, instruments that do not have fixed settlement provisions are deemed to be derivative instruments. In prior years, the Company granted certain warrants that resulted in these warrants being accounted for as a financial instrument in accordance with ASC 815 and being re-measured every reporting period with the change in value reported in the statement of operations. The financial instruments were valued using a variety of pricing models with the following valuation assumptions for the year ended December 31, 2021:
Schedule of financial instrument |  |  |  |
|  | December 31, 2021 |
Stock price |  | $ | 2.50 |
Exercise price |  | $ | 2.50 |
Contractually defined remaining term |  |  | 5.0 |
Contractually defined volatility |  |  | 135 | %
Dividend yield |  |  | 0 | %
Risk-free interest rate |  |  | 1.3 | %
Per the terms of the warrant agreements underlying the financial instruments, the value to the warrant holders is defined within the agreement based on a stock price, contractual term, volatility factor and dividend rate as defined in the warrant agreement, and not indexed to the company’s stock, resulting in the financial instrument accounting. The risk-free interest rate was based on rates established by the Federal Reserve Bank. The following table sets forth a summary of the changes in the estimated fair value of the financial instruments during the years ended December 31, 2022 and 2021:
Schedule of fair value of the financial instruments |  |  |  |  |  |  |  |
|  | December 31, |
|  | 2022 |  |  | 2021 |
Beginning balance |  | $ | 4,249,000 |  |  | $ | 4,192,000 |
Recognition of financial instruments |  |  | - |  |  |  | 4,239,000 |
Change in fair value |  |  | 17,000 |  |  |  | 542,000 |
Extinguishment |  |  | (4,266,000 | ) |  |  | (4,724,000 | )
Ending balance |  | $ | - |  |  | $ | 4,249,000 |
Advances from Related Parties As of December 31, 2022, the balance of advances from related parties was $0.3 million. This amount consists of unsecured, non-interest-bearing loans due on demand, which were borrowed in December 2022. $0.2 million of the balance was borrowed from Mr. Nisser, and $0.1 million was borrowed from Mr. Horne. These loans are not subject to written agreements.

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration